CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
NXTS
N2OFF, Inc.
There isn't enough reported data to score NXTS yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NXTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
NXTS's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
NXTS PE Valuation
NXTS has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
NXTS Forward outlook
There aren't enough analyst estimates for NXTS to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the stronger earnings trend. Trailing diluted EPS is up 718% for CELH versus NXTS down 119%.
NXTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$953.23 | +$4,020.27 |
| Q2 2025 | -$1,464.93 | +$5,211.32 |
| Q1 2025 | -$1,526.18 | +$5,725.82 |
| Q4 2024 | -$1,366.93 | +$8,739.32 |
| Q3 2024 | -$4,973.50 | +$3,381.00 |
| Q2 2024 | -$6,676.25 | +$3,613.75 |
| Q1 2024 | -$7,252.00 | +$5,953.50 |
| Q4 2023 | -$10,106.25 | +$3,956.75 |
NXTS is still losing money, but far less than before: $953.23 per share over the past year, against $19,036.50 at its worst in early 2022.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the stronger quarterly revenue trend. Revenue is up 17% for CELH versus down 78% for NXTS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
NXTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $2K | -78% |
| Q1 2025 | $66K | +51% |
| Q4 2024 | $140.5K | +33% |
| Q2 2024 | $16.5K | -55% |
| Q1 2024 | $43.8K | -64% |
| Q4 2023 | $105.8K | -53% |
| Q2 2023 | $36.6K | +18% |
| Q1 2023 | $121K | +38% |
NXTS's revenue is growing: $2,000 last quarter, down 78% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -66300% | -49277 points |
| Q1 2025 | -938% | +1113 points |
| Q4 2024 | -715% | +1304 points |
| Q3 2024 | -17023% | N/A |
| Q2 2024 | -5235% | -2940 points |
| Q1 2024 | -2051% | -610 points |
| Q4 2023 | -2019% | -1381 points |
| Q2 2023 | -2295% | +1813 points |
NXTS's operating margin was −66300% last quarter, down 61065 points from the same quarter a year ago, near the bottom of its range since 2020.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with NXTS at up 8.3%.
NXTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$540K | -$12K |
| Q1 2026 | -$1.5M | -$681K |
| Q3 2025 | -$974K | -$84.3K |
| Q2 2025 | -$528K | +$502K |
| Q1 2025 | -$809K | +$198.5K |
| Q4 2022 | -$974.5K | +$6.5K |
| Q2 2022 | -$1.3M | +$353.2K |
| Q1 2022 | -$1.1M | -$1M |
NXTS has burned cash in almost every quarter: −$4M over the past year, against −$3M the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
NXTS Net Leverage
NXTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
NXTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 15.3 | Oversold |
| Stochastic | 3.6 | Oversold |
NXTS's weekly RSI is 15 (oversold) and its Stochastic is 4 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
NXTS PE vs Consumer Defensive Sector
NXTS has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has stronger trend alignment. CELH is above 2 of 5 weekly averages versus NXTS above 0 of 2.
NXTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.06 | 50% below |
| 20 week MA | $8.07 | 75% below |
NXTS is in a downtrend: it's below all two of its weekly moving averages, and 75% below its 20-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over NXTS on returns for 2026, with the stronger performance.
NXTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $42.4 | $2.01 | -95% |
It's down 95% so far in 2026.